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ess: jtuggey@doctors.oSummary Non-invasive ventilation (NIV) is widely used for acute and chronic
respiratory failure. If arterial blood gas tensions do not improve, the level of support
can be increased. However, there may be a limit above which increasing ventilatory
support leads only to greater interface leak with no improvement in ventilation. The
aim of this study was to establish whether there is such a limit.
During a daytime study in 24 ventilated stable patients (10 with chronic
obstructive pulmonary disease (COPD), 14 with chest wall deformity, CWD),
inspiratory pressures up to 20 cmH2O and set tidal volumes up to 10ml kg
1 were
associated with mask leak of o5 lmin1. Although leak increased with higher levels
of support, there was still an increase in minute ventilation. The mean (2 SD)
tolerated pressure was 24 cmH2O (8–40) in both groups, and set tidal volume
12.7ml kg1 (5.0–20.4) in CWD and 9.6ml kg1 (3.9–14.8) in COPD. Measures of
respiratory effort were significantly reduced at all levels with both forms of
ventilatory support.
There is debate about whether the therapeutic aim of NIV should be to reduce
respiratory muscle effort, or to reverse nocturnal hypoventilation. We conclude that
if the primary aim is to improve arterial blood gas tensions and this is not achieved,
higher levels of ventilation can be obtained using greater pressure or volume,
despite additional interface leak. If the aim is to abolish muscle effort completely,
there is little to be gained by increasing the level of inspiratory pressure above 20
(CWD) or 25 (COPD) cmH2O.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserve
2066037;
rg.uk (J.M. Tuggey).Introduction
Non-invasive ventilation (NIV) in chronic respira-
tory failure due to chronic obstructive pulmonary
disease (COPD), chest wall deformity (CWD) and
neuromuscular disease is effective in terms ofd.
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sions2 and improving sleep architecture,3 oxygen
saturation and transcutaneous carbon dioxide dur-
ing sleep, as well as arterial blood gas tensions
during the day.4 Ventilator mode and settings used
are varied, usually directed initially by patient
comfort and then adjusted according to measure-
ments of gas tensions during wakefulness and
confirmed during sleep. If arterial blood gas
tensions do not improve the level of ventilatory
support can be increased. However, in patients with
severely compromised respiratory function there
may be a limit above which increasing the delivered
volume or pressure results in no improvement in
ventilation. It is analogous to trying to squeeze a
litre into a half litre container; increasing pressure
or volume beyond a certain level may lead only to
more interface leak without increased ventilation.
Anecdotally, there are regional differences in
practice amongst clinicians with some adopting a
maximal respiratory muscle rest approach, whilst
others adopt a ‘partial assistance’ approach. Inter-
face leak is common during NIV and is associated
with patient ventilator asynchrony, ineffective
efforts, persistent hypercapnia and frequent arou-
sals from sleep.5 In bench studies pressure targeted
ventilators perform better in the face of leak
than volume cycled flow generators6 whereas
volume cycled machines should be able to deliver
a higher tidal volume in the face of a high
impedance to inflation, but may just cause more
leak. In a recent Cochrane Review Annane et al.
called for studies to compare the different types
and modes of ventilation.7
The primary aim of this study was to test the null
hypothesis: ‘‘that increasing the level of ventila-
tory support above a certain level will lead to more
interface leak, without a clinically significant
increase in minute ventilation or reduction in the
pressure time product of the oesophageal wave-
form’’. A secondary aim was to compare pressure
and volume targeted ventilation in terms of minute
ventilation, leak and pressure time product of the
oesophageal waveform.Materials and methods
Subjects
The study protocol was approved by the Leeds
Teaching Hospitals Local Research Ethics Commit-
tee. Written informed consent was obtained from
patients. All patients were in stable chronic
respiratory failure (PaCO246.5 kPa with a normalpH) and free from exacerbations in the preceding 6
weeks. Patients were either using NIV (CWD group),
or had previously been compliant with NIV used
acutely (COPD group). All were non-smokers. No
patients were receiving long-term oxygen therapy
at the time of the study.
Study design
All measurements were made during the daytime
whilst the patient was awake in a semi-recumbent
position. Patients were kept in the same position
for the entire experiment. An interval of at least
2 h was allowed after taking any inhaled medication
prior to starting the experiment.
Methods
Static lung volumes were measured using a Micro-
Lab portable spirometer (Micromedical, Gilling-
ham, UK). Radial arterial blood gas tensions were
analysed using an automated analyser (IL-1604,
Instrumentation Laboratory, USA). Flow was mea-
sured using a heated pneumotachograph (Model
3700, Hans Rudolph, Kansas City, MO, USA), placed
between the nasal mask and the expiratory valve of
the ventilator circuit. The pneumotachograph was
calibrated before each experimental run. Mask
pressure was measured using a pressure transducer
(MPX 5100, Motorola, Denver, CO, USA) connected
to one port of the nasal mask. Oesophageal
pressure (Poes) was measured using a latex balloon
catheter (Ackrad Laboratories, Cranford, NJ, USA)
connected to a further pressure transducer. The
catheter was passed using standard techniques.8
Once settled, patients were asked to breath
through the nasal mask with the mouth shut to
obtain baseline spontaneous expired tidal volume
(VTe), respiratory rate (fR) and pressure–time
product of the oesophageal waveform (PTPoes) as
described below.
Non-invasive ventilation
Before commencing the ventilator experiment,
patients spent a short period using their usual
home ventilator (CWD patients) or the machine
they had previously used acutely (COPD patients)
both to ensure optimal mask fit with minimal leak,
and to establish inspired tidal volume (VTi) and
inspiratory time (tI) with their usual (or previous)
settings. This was performed using pressure-tar-
geted ventilation, as is the routine in this depart-
ment. Patients used individual nasal masks that
they had used previously. The same mask was used
throughout the experimental protocol. Patients
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protocol was started and were encouraged to
remain as still as possible with their mouth closed
to minimise fluctuations in mask leak. The backup
rate at which there were no inspiratory triggering
efforts was identified and used for the subsequent
experiments (i.e. patients receive controlled ven-
tilation). In case patients made additional inspira-
tory efforts the inspiratory trigger was set at the
most sensitive without autocycling (typically
—0.1 cmH2O). We chose a controlled ventilation
approach since previous observations within our
unit have demonstrated that these patients depend
upon a relatively high backup rate to maintain
adequate minute ventilation and gas exchange.
Both modes of ventilation (pressure or volume)
were delivered using the same ventilator (PV403,
Breas, Mo¨lnlycke, Sweden). This ventilator was
chosen since it offers both modes of ventilation,
and settings can be easily and precisely altered.
Patients were aware that ventilator settings were
being altered, but were blinded as to which mode
and what level of support was being given.Volume ventilation
Inspiratory time was adjusted in increments of 0.1 s
to find the patient’s preferred setting. This process
was repeated three times or until the patient chose
consistently within 70.1 s. Having set tI, VTi was
then adjusted in increments of 100ml through a
range whose limits were set by patient tolerability.
Patients were kept at each setting for at least
3min, or until VTe had stabilised. This process was
again repeated three times, randomly in ascending
or descending order.Pressure ventilation
The starting level of inspiratory pressure support
(IPAP) was that used by the patient previously.
Plateau (rise time) was adjusted according to
comfort, which tended to be the shortest rise time
possible. Expiratory trigger was again altered
according to patient comfort, and was usually 40%
(i.e. inspiratory flow had to fall to 40% of peak flow
in order to cycle into expiration). IPAP was then
altered in increments of 5 between 10 and
40 cmH2O, limited by patient tolerance. As before,
patients were kept at each setting for at least
3min, or until VTe had stabilised.
Flow and pressure were recorded during the last
60 s of each experimental run. VTi and VTe,
respiratory frequency (fR), and expired minute
ventilation (V0E) were calculated. Minute leak was
calculated as the difference between VTi and VTemultiplied by respiratory rate. The pressure–time
product (PTPoes) of the oesophageal pressure was
measured by calculating the integral of Poes and the
inspiratory time. Inspiration was defined as the
onset of a (relative) negative swing of the Poes
tracing. The end of inspiration was identified by
restoration of the Poes to pre-inspiration levels.
9
Gastric balloons were not passed and therefore no
estimate of expiratory muscle activity or calcula-
tion of intrinsic positive end expiratory pressure
could be obtained. PTPoes/VTe was used as an index
of respiratory muscle activity because it correlates
with oxygen uptake of inspiratory muscles.10
Inspiratory efforts not resulting in a ventilator
supported breath were recorded as ineffective
efforts.11
Having established the relationship between set
pressure or tidal volume and the resultant minute
volumes, pressure- and volume ventilation were
compared directly in terms of leak and PTPoes.
Using regression analysis, the necessary set pres-
sure or tidal volumer required to achieve minute
volumes of 12, 14, 16 and 18 lmin1 were calcu-
lated from the pooled data. The corresponding leak
and PTPoes/V0E were then estimated.
Statistical analysis
Results are described as mean7standard error of
the mean. COPD and CWD patients were analysed
separately. Primary endpoints were expired minute
ventilation (V0E) and minute leak; a secondary
endpoint was PTPoes/V0E. Set tidal volume was
expressed as ml kg1 to enable comparisons. One
way analysis of variance (ANOVA) was used to assess
if there was any significant difference overall
between the settings for each patient group and
ventilatory mode.Results
Twenty-four patients (14 with CWD, 10 with COPD)
were recruited (Table 1). Both groups had severely
impaired lung function with daytime hypercapnia
(despite receiving domiciliary NIV in the CWD
group). All patients tolerated the transition from
their usual ventilator to the PV 403 for the purpose
of the experiment. At extremes of the ranges of
pressure and volume (e.g. greater than 40 cmH2O or
20ml kg1 in CWD group, 16ml kg1 in the COPD
group), patients found the settings uncomfortable
and when this occurred, pressure or volume was
returned to a lower level. Patients did however
tolerate a wide range of pressures and volumes.
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Table 1 Demographic, anthropometric and functional characteristics of patients.
Characteristic CWD (mean7SD) COPD (mean7SD)
Age (years) 6079 63713
Male/female (n) 7/7 9/1
Weight (kg) 63712 102722
FEV1 (% predicted) 0.6070.13 (26%) 0.9370.17 (35%)
FVC (% predicted) 0.6970.15 (25%) 2.0170.61 (54%)
FEV1/FVC, % 8778 50710
pH* 7.3870.02 7.3870.03
PaO2 (kPa)* 8.870.9 7.771.3
PaCO2 (kPa)* 6.570.3 7.071.0
Kyphoscoliosis (n) 12 —
Thoracoplasty (n) 2 —
FEV1: Forced expiratory volume in 1 s; FVC: forced vital capacity; PaO2, PaCO2: arterial partial pressures of oxygen and carbon
dioxide.*Blood gas tensions refer to daytime spontaneous ventilation.
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Figure 1 The effect of changes in either set pressure (a and b) or set tidal volume (c and d) on minute ventilation (V0E),
minute leak and pressure-time product oesophagus (PTPoes). Spont: spontaneous unsupported ventilation.
Titration of non-invasive ventilation 1265The mean pressure (2 SD) tolerated was 24 cmH2O
(8–40) for both patient groups. The mean tolerated
set VTi was 12.7ml kg
1 (5.0–20.4) in CWD and
9.6ml kg1 (3.9–14.8) in COPD. Only those settings
which patients found acceptable were subse-
quently analysed. The relation between set para-
meter (pressure or volume) and minute ventilation,
minute leak and PTPoes/V0E are shown in Fig. 1.Ventilation and leak
Within the limits of patient tolerability, minute
ventilation could be improved by increases in either
set pressure or volume (Fig. 1). Low levels of
pressure (10 cmH2O) or volume (6ml kg1) sup-
port delivered minute ventilation that was similar
to spontaneous ventilation. However, even at these
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the oesophageal waveform was significantly re-
duced compared to unassisted ventilation, with a
drop in PTPoes in both modes of ventilation
(Po0.01). Pressures above 20–25 cmH2O and tidal
volumes above 6ml kg1 did not lead to further
reductions in the PTPoes (Fig. 1).
With increasing support, there is an increase in
mask leak. During pressure ventilation, set pres-
sures over 20 cmH2O are associated with increasing
leak. The confidence intervals suggest that at
higher pressures, leak is very variable on a
patient-by-patient basis. Despite this increase in
leak, there is a continuing rise in minute ventila-
tion. A similar pattern is seen during volume
ventilation, with increases in leak above 10ml kg1
in CWD and 8ml kg1 in COPD patients. In contrast
to other studies, there were few ineffective
efforts. These tended to occur at extremes of
pressure or volume, particularly in association with
high levels of leak. There were no episodes of
autocycling.Comparison of pressure and volume
ventilation
By using the data from Fig. 1, it was possible to
identify the required set pressure and tidal volumes
to achieve minute ventilations of 12, 14, 16 and
18 lmin1. Using the figures, an estimate was made
of the minute leak and PTPoes for pressure- and
volume-targeted ventilation to achieve these min-
ute volumes. Due to the heterogeneity of the data
for the COPD patients, this was only possible in the
CWD group. At minute ventilations between 12 and
18 lmin1, there was equivalence between pres-
sure and volume targeted ventilation in terms of
both mask leak and PTPoes.Discussion
The null hypothesis ‘‘that increasing the level of
ventilatory support above a certain level will only
lead to more interface leak, without a clinically
significant increase in minute ventilation or reduc-
tion in the pressure time product of the oesopha-
geal waveform’’ was not confirmed in this study.
Higher levels of minute ventilation can be achieved
with increasing levels of pressure or volume
ventilation, though there is an increase in mask
leak. There is a significant reduction in PTPoes even
at low levels of support but once IPAP is greater
than 20 cmH2O or set VT more than 6ml kg
1further reductions are small.12 These findings were
true in both patients with CWD and COPD.
There is currently no clearly defined primary aim
of ventilatory support during NIV.13 Usual aims are
to either improve gas exchange or unload the
inspiratory muscles. Kimura et al. 12 suggested that
ventilation should aim to keep Poes to near zero.
This group suggested that high levels of pressure
support would not load the respiratory muscles
sufficiently, resulting in deconditioning and atro-
phy. There is evidence from animal experiments
that continuous, invasive ventilation does result in
a reduction in diaphragmatic endurance and
strength.14 Whilst ventilatory-induced diaphrag-
matic dysfunction may occur in patients undergoing
full invasive ventilation, this is not the same
situation for patients undergoing intermittent NIV.
Nava et al.15 demonstrated an improvement in
diaphragm strength after 4 weeks of intermittent
NIV in COPD. These patients have periods during
spontaneous breathing when the respiratory mus-
cles are working against an increased load, which
should be more effective than partial assistance at
preventing atrophy of the respiratory muscles. It
could be argued that this is an ideal training
regime; periods of complete rest and of high
intensity work, though this remains speculative.
During controlled ventilation both Carrey et al.16
and Elliott et al.17 demonstrated positive oesopha-
geal pressure swings and improvements in ventila-
tion. There may be benefit of positive Poes swings in
terms of improving atelectasis and chest wall
compliance, particularly in patients with
CWD.18,19 Reducing the work of the inspiratory
muscles as much as possible during NIV is probably,
though not definitely, desirable. At higher levels of
ventilatory support, it is possible that ‘ventilator
Ti’ outlasts ‘neural Ti’ and this would be a factor
against pursuing higher levels of ventilator support.
However, prolongation of the inspiratory time will
result in more efficient ventilation, allowing more
time for gas exchange to occur in lung units with
long time constants. There is a potential risk of
greater hyperinflation, particularly in patients with
COPD.20 However, during controlled ventilation as
in this study, the backup rate during NIV was lower
than the spontaneous respiratory rate of these
patients (15.4 vs. 19.4min1), allowing greater
time for lung emptying than when breathing
spontaneously. Fauroux et al.21 demonstrated
reductions in respiratory effort amongst children
with cystic fibrosis undergoing NIV at higher backup
rates.
With regard to the suggestion that increasing
ventilatory support beyond a certain level just
increases leak without increasing ventilation, in a
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and others have shown an interaction between bi-
level pressure ventilation and glottic aperture,
potentially limiting minute ventilation.22–25 The
same group recognised that during these experi-
ments, significant hypocapnia was induced, which
they suggested abolished hypoxemic drive and
resulted in passive glottic narrowing as a conse-
quence of this reduced ventilatory drive, rather
than direct physical narrowing.26 Our data using
patients rather than normal subjects does not
support this as in all patients there was a
continuous rise in minute ventilation compared to
unassisted ventilation with increasing levels of
pressure support. Some glottic closure may explain
the increasing mask leak. Bulging of the supraglot-
tic area has been noticed with higher pressures
during NIV.25 However, importantly, despite in-
creased leak at higher pressures or volumes, we
observed still worthwhile increases in minute
ventilation.
Our data is consistent with other studies using
PSV in stable COPD patients which have shown a
continuous improvement in V0E, gas exchange and
reduction in Pdi or diaphragmatic EMG with in-
creasing pressure support.11 Similar results have
been found in acute exacerbations of COPD with
benefits gained at higher levels of pressure sup-
port.27 Despite this, at high levels of support (e.g.
IPAP of 40 cmH2O) there is still a small, but
significant level of patient effort. This represents
patient’s ‘joining in’ with ventilation, where work
is performed during the inspiratory phase, but not
necessarily in triggering the ventilator. The absence
of significant ineffective efforts in this study is in
contrast to others.11 This is not surprising as the
majority of ventilated breaths were controlled.Limitations of this study
Leak is common during NIV, particularly during
sleep and varies with sleep stage.5 Measurements
were made during the daytime, in awake seated or
semi-recumbent position and therefore may not
correlate with what happens during sleep at night,
when NIV is usually, but not always applied.28 It is
likely that the changes we observed with varying
degrees of ventilatory support are applicable at
night, although mask leak may be overall greater. In
addition, patients are more likely to leak through
the mouth at night.5 Whilst patients could tolerate
short periods of relatively high inflation pressures
or tidal volumes during the daytime, these may
have a deleterious effect on sleep quality. This
would be suitable for an overnight study comparing‘high’ vs. ‘low’ ventilation strategies, whilst also
performing polysomnography.
It would have been useful to have measured
arterial blood gas tensions at each setting to
identify whether these changes affect not just
minute ventilation but actual gas exchange. It was
felt to be unethical either to perform repeated
blood gas measurements or to insert an arterial
cannula. Since improvements in minute ventilation
were achieved with greater tidal volumes and a
reduction in respiratory rate, it is reasonable to
infer that alveolar ventilation and therefore PaCO2
would have improved. Pulse oximetry was mea-
sured during the experiment but was not sensitive
to change. Similarly, transcutaneous CO2 measure-
ments were used during an initial pilot study, but
were not found to be consistent and responded too
slowly within the timescale used at each ventilator
setting.
In this protocol, patients were limited to one
ventilator, the Breas PV403. Caution would have to
be taken in extrapolating this data to all forms of
non-invasive ventilator. Other machines differ in
the way they cycle between inspiration and
expiration and trigger sensitivity. Subtle changes
in cycling and triggering can have significant effects
on leak, work of breathing and comfort. Prinianakis
et al.,29 have shown that faster rates of pressurisa-
tion lead to a greater reduction in work of breath-
ing but more leak and patient discomfort. However,
the fact that we chose a high back up rate, such
that most breaths were controlled minimises the
impact of any differences in inspiratory trigger
performance. The ventilator used does not provide
any form of expiratory positive airways pressure
support (EPAP). The presence of intrinsic positive
end expiratory pressure is significant, particularly
in patients with acute exacerbations of COPD.
Because the COPD patients in this study were in the
stable state, and ventilation was controlled, the
absence of any EPAP is unlikely to have significantly
affected the results. Indeed, if EPAP had been
provided, the reduction in pressure time product of
the oesophagus would have been greater during the
assisted breaths.
We looked at the effects of ventilator settings in
patients in the chronic stable state and the findings
cannot necessarily be extrapolated to the acute
setting. Furthermore, it was performed in indivi-
duals already acclimatised to NIV who may have
been more likely to tolerate higher levels of
support or mask leak than NIV naı¨ve patients. The
COPD group studied happened to be obese (mean
weight 102 kg), and it is possible that these patients
also suffered with a degree of obesity hypoventila-
tion. The study was performed in the daytime
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less likely to be a confounding issue.
Recent work has identified the importance of
mask design and particularly the effect of fit on
triggering and leak.30 We did not use the same mask
in all patients, but rather the mask that individual
patients were used to, and had found to be best for
them in terms of leak and comfort. It is possible
that less mask leak would been seen with some
newer mask designs; if this was the case even
greater increases in ventilation would be likely at
higher levels of support.
It would have been useful to include an assess-
ment of patient comfort with each setting. It was
felt that this would be unrealistic due to the wide
range of settings used over very short periods of
time. Whilst an individual may find relatively ‘high’
levels of support initially uncomfortable, if the
same level is reached by gradually increasing the
level of support over some time (as is routine
clinical practice), then a very different perception
of comfort will be obtained. Clinical observation
certainly suggests that when starting NIV some
patients may only be able to tolerate low levels of
support, but as they acclimatise the level can be
gradually increased. The group of patients ob-
served in this study were not ventilator naı¨ve and
were therefore more likely to tolerate higher levels
of support compared to an individual experiencing
NIV for the first time. Patient comfort, tolerance
and consequent compliance is essential during
NIV.5,31,32 There is wide variation in reported
comfort both between and within individuals using
different non-invasive ventilators.33 It is important
therefore that any decision regarding ventilator
setting is made in the context of the patient, their
comfort and the specific ventilator used.Conclusion
Further studies are needed to establish the correct
target for NIV, in particular whether the aim should
be complete abolition of respiratory muscle activ-
ity, with its theoretical risk of disuse atrophy,
partial reduction into the range of normal, or
control of hypoventilation and improvement in gas
tensions overnight. If adequate control of arterial
blood gas tensions is the primary aim, and this is
not achieved with moderate levels of ventilatory
support greater minute ventilation can be achieved
by using higher levels. During pressure ventilation,
which is increasingly the mode of choice, pressures
of up to 20 cmH2O result in little leak. Increasing
pressure above this level is associated with greaterleak in some, but not all patients and does result in
increased minute ventilation. There is a significant
reduction in PTPoes at all levels of pressure or
volume support but if this is the primary goal of
therapy there is little to be gained by increasing
IPAP above 20 (CWD) to 25 (COPD) cmH2O. There is
no difference between pressure and volume tar-
geted ventilation when comparing equivalent de-
livered minute ventilation. This study suggests that
if NIV is failing higher levels of ventilatory support
should not be avoided because of concerns about
excessive interface leak.Acknowledgements
JT was funded by the NHS Northern & Yorkshire
Executive. Ventilators were loaned from Breas (UK)
Limited.References
1. Hill NS, Eveloff SE, Carlisle CC, Goff SG. Efficacy of
nocturnal nasal ventilation in patients with restrictive
thoracic disease. Am Rev Respir Dis 1992;145:365–71.
2. Bach JR, Alba AS. Management of chronic alveolar hypo-
ventilation by nasal ventilation. Chest 1990;97:52–7.
3. Ellis ER, Grunstein RR, Chan S, Bye PTB, Sullivan CE.
Noninvasive ventilatory support during sleep improves
respiratory failure in kyphoscoliosis. Chest 1988;94:811–5.
4. Simonds AK, Elliott MW. Outcome of domiciliary nasal
intermittent positive pressure ventilation in restrictive and
obstructive disorders. Thorax 1995;50:604–9.
5. Teschler H, Stampa J, Ragette R, Konietzko N, Berthon-
Jones M. Effect of mouth leak on effectiveness of nasal
bilevel ventilatory assistance and sleep architecture. Eur
Respir J 1999;14:1251–7.
6. Mehta S, McCool FD, Hill NS. Leak compensation in positive
pressure ventilators: a lung model study. Eur Respir J
2001;17(2):259–67.
7. Annane D, Chevrolet JC, Chevret S, Raphael JC. Nocturnal
mechanical ventilation for chronic hypoventilation in pa-
tients with neuromuscular and chest wall disorders. Co-
chrane Database Syst Rev 2000(2):CD001941.
8. Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J. A
simple method for assessing the validity of the Esophageal
Balloon Technique. Am Rev Respir Dis 1982;126:788–91.
9. Collett PW, Perry C, Engel LA. Pressure-time product, flow,
and oxygen cost of resistive breathing in humans. J Appl
Physiol 1985;58(4):1263–72.
10. Field S, Sanci S, Grassino A. Respiratory muscle oxygen
consumption estimated by diaphragm pressure time inte-
gral. J Appl Physiol 1984;57:44–51.
11. Vitacca M, Nava S, Confalonieri M, Bianchi L, Porta R, Clini E,
et al. The appropriate setting of noninvasive pressure
support ventilation in stable COPD patients. Chest 2000;
118:1286–93.
12. Kimura T, Takezawa J, Nishiwaki K, Shimada Y. Determination
of the optimal pressure support level evaluated by measuring
transdiaphragmatic pressure. Chest 1991;100(1):112–7.
13. Elliott MW. Non-invasive ventilation—mechanisms of bene-
fit. Med Klin 1999;94:2–6.
ARTICLE IN PRESS
Titration of non-invasive ventilation 126914. Le Bourdelles G, Viires N, Boczkowski J, Seta N, Pavlovic D,
Aubier M. Effects of mechanical ventilation on diaphrag-
matic contractile properties in rats. Am J Respir Crit Care
Med 1994;149(6):1539–44.
15. Nava S, Fanfulla F, Frigerio P, Navalesi P. Physiologic
evaluation of 4 weeks of nocturnal nasal positive pressure
ventilation in stable hypercapnic patients with chronic
obstructive pulmonary disease. Respiration 2001;68(6):
573–83.
16. Carrey Z, Gottfried SB, Levy RD. Ventilatory muscle support
in respiratory failure with nasal positive pressure ventila-
tion. Chest 1990;97:150–8.
17. Elliott MW, Aquilina R, Green M, Moxham J, Simonds AK. A
comparison of different modes of noninvasive ventilatory
support: effects on ventilation and inspiratory muscle
effort. Anaesthesia 1994;49:279–83.
18. Bergofsky EH. Respiratory failure in disorders of the thoracic
cage. Am Rev Respir Dis 1979;119:643–69.
19. Hoeppner VH, Cockcroft DW, Dosman JA, Cotton DJ. Night-
time ventilation improves respiratory failure in secondary
kyphoscoliosis. Am Rev Respir Dis 1984;129:240–3.
20. Giannouli E, Webster K, Roberts D, Younes M. Response of
ventilator-dependent patients to different levels of pressure
support and proportional assist. Am J Respir Crit Care Med
1999;159(6):1716–25.
21. Fauroux B, Louis B, Hart N, Essouri S, Leroux K, Clement A,
et al. The effect of back-up rate during non-invasive
ventilation in young patients with cystic fibrosis. Intensive
Care Med 2004;30(4):673–81.
22. Jounieaux V, Aubert G, Dury M, Delguste P, Rodenstein DO.
Effects of nasal positive-pressure hyperventilation on the
glottis in normal awake subjects. J Appl Physiol 1995;79(1):
176–85.
23. Parreira VF, Jounieaux V, Aubert G, Dury M, Delguste PE,
Rodenstein DO. Nasal two-level positive-pressure ventilation
in normal subjects. Effects of the glottis and ventilation. Am
J Respir Crit Care Med 1996;153(5):1616–23.
24. Parreira VF, Delguste P, Jounieaux V, Aubert G, Dury M,
Rodenstein DO. Effectiveness of controlled and spontaneousmodes in nasal two-level positive pressure ventilation in
awake and asleep normal subjects. Chest 1997;112(5):
1267–77.
25. Parreira VF, Delguste P, Jounieaux V, Aubert G, Dury M,
Rodenstein DO. Glottic aperture and effective minute
ventilation during nasal two-level positive pressure ventila-
tion in spontaneous mode. Am J Respir Crit Care Med
1996;154:1857–63.
26. Jounieaux V, Parreira VF, Aubert G, Dury M, Delguste P,
Rodenstein DO. Effects of hypocapnic hyperventilation on
the response to hypoxia in normal subjects receiving
intermittent positive-pressure ventilation. Chest 2002;
121(4):1141–8.
27. Brochard L, Isabey D, Piquet J, Amaro P, Mancebo J, Messadi
AA, et al. Reversal of acute exacerbations of chronic
obstructive lung disease by inspiratory assistance with a
face mask. N Engl J Med 1990;323:1523–30.
28. Scho¨nhofer B, Geibel M, Sonnerborn M, Kohler D. Daytime
mechanical ventilation in chronic respiratory insufficiency.
Eur Respir J 1997;10:2840–6.
29. Prinianakis G, Delmastro M, Carlucci A, Ceriana P,
Nava S. Effect of varying the pressurisation rate during
noninvasive pressure support ventilation. Eur Respir J 2004;
23:314–20.
30. Schettino GP, Tucci MR, Sousa R, Valente Barbas CS, Passos
Amato MB, Carvalho CR. Mask mechanics and leak dynamics
during noninvasive pressure support ventilation: a bench
study. Intensive Care Med 2001;27(12):1887–91.
31. Criner GJ, Brennan K, Travaline JM, Kreimer D. Efficacy and
compliance with noninvasive positive pressure ventilation in
patients with chronic respiratory failure. Chest 1999;
116(3):667–75.
32. Meecham Jones DJ, Braid GM, Wedzicha JA. Nasal masks for
domiciliary positive pressure ventilation: patient usage and
complications. Thorax 1994;49:811–2.
33. Vitacca M, Barbano L, D’Anna S, Porta R, Bianchi L,
Ambrosino N. Comparison of five bilevel pressure ventilators
in patients with chronic ventilatory failure: a physiologic
study. Chest 2002;122(6):2105–14.
